CO2022010431A2 - Nuevo derivado de pirazol - Google Patents
Nuevo derivado de pirazolInfo
- Publication number
- CO2022010431A2 CO2022010431A2 CONC2022/0010431A CO2022010431A CO2022010431A2 CO 2022010431 A2 CO2022010431 A2 CO 2022010431A2 CO 2022010431 A CO2022010431 A CO 2022010431A CO 2022010431 A2 CO2022010431 A2 CO 2022010431A2
- Authority
- CO
- Colombia
- Prior art keywords
- pyrazole derivative
- new pyrazole
- new
- salt
- pharmaceutical composition
- Prior art date
Links
- 150000003217 pyrazoles Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- -1 pyrazole derivative compound Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
La presente invención proporciona un compuesto derivado de pirazol novedoso representado por la fórmula química I o una sal del mismo, y una composición farmacéutica que comprende el mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20200004471 | 2020-01-13 | ||
PCT/KR2021/000425 WO2021145655A1 (ko) | 2020-01-13 | 2021-01-12 | 신규한 피라졸 유도체 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2022010431A2 true CO2022010431A2 (es) | 2022-08-09 |
Family
ID=76864348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2022/0010431A CO2022010431A2 (es) | 2020-01-13 | 2022-07-26 | Nuevo derivado de pirazol |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230067461A1 (es) |
EP (1) | EP4105206A4 (es) |
JP (1) | JP2023511302A (es) |
KR (1) | KR102333863B1 (es) |
CN (1) | CN114945561A (es) |
AU (1) | AU2021208915B2 (es) |
BR (1) | BR112022013849A2 (es) |
CA (1) | CA3167675A1 (es) |
CL (1) | CL2022001888A1 (es) |
CO (1) | CO2022010431A2 (es) |
IL (1) | IL294674A (es) |
MX (1) | MX2022008665A (es) |
WO (1) | WO2021145655A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022182205A1 (ko) | 2021-02-25 | 2022-09-01 | 압타바이오 주식회사 | 신규한 피라졸 유도체 |
EP4320233A1 (en) | 2021-04-07 | 2024-02-14 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
WO2023191201A1 (ko) * | 2022-03-31 | 2023-10-05 | 압타바이오 주식회사 | 신규한 피라졸 유도체 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK574976A (da) * | 1976-01-16 | 1977-07-17 | Du Pont | Substituerede cycloalkanpyrazoler samt deres fremstilling og anvendelse |
DE3832348A1 (de) * | 1988-03-10 | 1989-09-28 | Bayer Ag | Substituierte benzoxazinone, mehrere verfahren sowie neue zwischenprodukte zu ihrer herstellung sowie ihre herbizide verwendung |
DE3917469A1 (de) * | 1989-05-30 | 1990-12-06 | Bayer Ag | Heterocyclylpyridine |
DE4023488A1 (de) * | 1990-07-24 | 1992-01-30 | Bayer Ag | 1-(pyri(mi)dyl-(2)) -5-hydroxy-pyrazol-mikrobizide |
AU2697092A (en) * | 1991-10-08 | 1993-05-03 | Nippon Soda Co., Ltd. | Pyrazole derivative and agrohorticultural bactericide containing same |
KR100289470B1 (ko) * | 1999-02-25 | 2001-05-02 | 김충섭 | 제초활성을 가지는 2-(5-이속사졸린메틸옥시페닐)-4,5,6,7-테트라히드로-2h-인다졸 유도체 |
AR045037A1 (es) * | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
JP5069907B2 (ja) * | 2003-09-17 | 2012-11-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 縮合複素環式化合物 |
KR100863692B1 (ko) * | 2006-12-08 | 2008-10-15 | 울산대학교 산학협력단 | 퇴행성질환 및 염증질환에 대한 예방치료 효과를 갖는7-하이드록시-6-메톡시-1,2,3,4-테트라하이드로이소퀴놀린유도체 |
CL2008000793A1 (es) * | 2007-03-23 | 2008-05-30 | Xenon Pharmaceuticals Inc | Compuestos derivados de dihidroindazol; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno del hierro. |
EP2151433A1 (en) * | 2008-08-05 | 2010-02-10 | Institut Pasteur | Alkoxypyrazoles and the process for their preparation |
TWI389913B (zh) * | 2008-09-08 | 2013-03-21 | Lg Life Sciences Ltd | 并合雜環化合物 |
FR2953839A1 (fr) * | 2009-12-14 | 2011-06-17 | Sanofi Aventis | Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75 |
EP2361911A1 (en) * | 2010-02-18 | 2011-08-31 | GenKyoTex SA | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
EP2361912A1 (en) * | 2010-02-18 | 2011-08-31 | GenKyoTex SA | Pyrazolo piperidine derivatives as NADPH oxidase inhibitors |
KR20120098462A (ko) * | 2011-02-28 | 2012-09-05 | 이화여자대학교 산학협력단 | 피라졸 유도체, 이의 제조방법 및 이를 포함하는 골다공증 예방 및 치료용 조성물 |
TWI599567B (zh) * | 2013-03-14 | 2017-09-21 | 健生藥品公司 | P2x7調節劑 |
CN106132967B (zh) | 2014-03-27 | 2019-05-28 | 詹森药业有限公司 | 作为ros1抑制剂的化合物 |
EP3134406A1 (en) * | 2014-04-24 | 2017-03-01 | Dart Neuroscience (Cayman) Ltd | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2h-pyrazolo [4,3-c]pyridine compounds as glyt1 inhibitors |
CA2989098A1 (en) | 2015-06-22 | 2016-12-29 | Actelion Pharmaceuticals Ltd | Nadph oxidase 4 inhibitors |
JP6508721B2 (ja) | 2015-09-28 | 2019-05-08 | 株式会社Screenホールディングス | 基板処理方法および基板処理装置 |
MA50417A (fr) * | 2017-10-18 | 2020-08-26 | Epizyme Inc | Procédés d'utilisation d'inhibiteurs de l'ehmt2 dans le traitement ou la prévention de troubles du sang |
JP2021500327A (ja) * | 2017-10-18 | 2021-01-07 | エピザイム,インコーポレイティド | 免疫療法にehmt2阻害剤を使用する方法 |
WO2019141957A1 (en) * | 2018-01-19 | 2019-07-25 | Cado Biotechnology Ivs | N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof |
-
2021
- 2021-01-12 KR KR1020210004079A patent/KR102333863B1/ko active IP Right Grant
- 2021-01-12 WO PCT/KR2021/000425 patent/WO2021145655A1/ko active Application Filing
- 2021-01-12 JP JP2022543171A patent/JP2023511302A/ja active Pending
- 2021-01-12 MX MX2022008665A patent/MX2022008665A/es unknown
- 2021-01-12 AU AU2021208915A patent/AU2021208915B2/en active Active
- 2021-01-12 EP EP21740932.5A patent/EP4105206A4/en active Pending
- 2021-01-12 IL IL294674A patent/IL294674A/en unknown
- 2021-01-12 BR BR112022013849A patent/BR112022013849A2/pt not_active Application Discontinuation
- 2021-01-12 CA CA3167675A patent/CA3167675A1/en active Pending
- 2021-01-12 US US17/791,983 patent/US20230067461A1/en active Pending
- 2021-01-12 CN CN202180009272.6A patent/CN114945561A/zh active Pending
-
2022
- 2022-07-12 CL CL2022001888A patent/CL2022001888A1/es unknown
- 2022-07-26 CO CONC2022/0010431A patent/CO2022010431A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2021208915B2 (en) | 2024-02-22 |
US20230067461A1 (en) | 2023-03-02 |
CL2022001888A1 (es) | 2023-02-24 |
AU2021208915A1 (en) | 2022-09-01 |
KR20210091063A (ko) | 2021-07-21 |
BR112022013849A2 (pt) | 2022-09-13 |
CA3167675A1 (en) | 2021-07-22 |
JP2023511302A (ja) | 2023-03-17 |
WO2021145655A1 (ko) | 2021-07-22 |
CN114945561A (zh) | 2022-08-26 |
EP4105206A4 (en) | 2024-08-14 |
KR102333863B1 (ko) | 2021-12-03 |
MX2022008665A (es) | 2022-08-10 |
IL294674A (en) | 2022-09-01 |
EP4105206A1 (en) | 2022-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2022010431A2 (es) | Nuevo derivado de pirazol | |
NI202000092A (es) | Compuestos | |
DOP2019000193A (es) | Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende | |
MX2019014104A (es) | Compuesto novedoso de bifenilo o sal del mismo. | |
UY36712A (es) | Derivados de pirimidiniloxi benceno como herbicidas | |
CL2020001752A1 (es) | Derivado de oxi-fluoropiperidina como inhibidor de quinasa. | |
CO2021001849A2 (es) | Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende | |
ECSP21015020A (es) | Pirazoles fungicidas sustituidos con nitroanilino | |
CO2021017706A2 (es) | Pirrolidinonas sustituidas con pirazol como herbicidas | |
CL2023000200A1 (es) | Nuevo derivado de pirazol | |
MX2020004842A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
MX2018004055A (es) | Compuestos de imino con un sustituyente de 2-cloropirimidin-5-ilo como agentes de control de plagas. | |
CL2020000940A1 (es) | Nuevo derivado de fenilpiridina y composición farmacéutica que lo contiene. | |
CO2018007668A2 (es) | Composición para el control de plagas y método para el control de plagas | |
CL2019002025A1 (es) | Derivados de pirrolotriazina como inhibidor de cinasas. | |
AR083438A1 (es) | Composicion que controla las plagas y metodo para controlarlas | |
CY1124177T1 (el) | Ενωσεις χρησιμες για την αναστολη του ror-γαμμα-τ | |
MX2019007786A (es) | Compuestos sustituidos de guanidina. | |
CR10979A (es) | Combinacion de herbicidas | |
CO2019005949A2 (es) | Combinación herbicida que contiene triafamona e indaziflam | |
CO2022008127A2 (es) | Procesos e intermediario para la preparación de oxetan-2-ilmetanamina | |
AR115689A1 (es) | Compuestos de uracilo y su utilización | |
GT200600132A (es) | Una oxindoloxazolidinona como agente antibacteriano | |
TH174565A (th) | อนุพันธ์เตตระไฮโดรไพรานิล เบนซาไมด์ | |
MY189798A (en) | Novel biphenyl compound or salt thereof |